Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Cash from Financing Activities (2016 - 2025)

Lisata Therapeutics filings provide 13 years of Cash from Financing Activities readings, the most recent being $205000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Financing Activities rose 313.54% year-over-year to $205000.0, compared with a TTM value of $599000.0 through Dec 2025, up 390.78%, and an annual FY2025 reading of $599000.0, up 390.78% over the prior year.
  • Cash from Financing Activities hit $205000.0 in Q4 2025 for Lisata Therapeutics, down from $353000.0 in the prior quarter.
  • The five-year high for Cash from Financing Activities was $452000.0 in Q2 2023, with the low at -$142000.0 in Q1 2024.
  • Median Cash from Financing Activities over the past 3 years was $24000.0 (2023), compared with a mean of $70727.3.
  • The sharpest move saw Cash from Financing Activities tumbled 500.0% in 2024, then soared 313.54% in 2025.
  • Year by year, Cash from Financing Activities stood at $24000.0 in 2023, then plummeted by 500.0% to -$96000.0 in 2024, then soared by 313.54% to $205000.0 in 2025.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at $205000.0, $353000.0, and $64000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.